ATE500826T1 - Verwendung von azabicyclohexan-derivaten - Google Patents
Verwendung von azabicyclohexan-derivatenInfo
- Publication number
- ATE500826T1 ATE500826T1 AT06777058T AT06777058T ATE500826T1 AT E500826 T1 ATE500826 T1 AT E500826T1 AT 06777058 T AT06777058 T AT 06777058T AT 06777058 T AT06777058 T AT 06777058T AT E500826 T1 ATE500826 T1 AT E500826T1
- Authority
- AT
- Austria
- Prior art keywords
- disorder
- nervosa
- hyperchondriasis
- sydeham
- paraphilia
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 abstract 2
- 208000000103 Anorexia Nervosa Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 206010004716 Binge eating Diseases 0.000 abstract 1
- 208000032841 Bulimia Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 206010008748 Chorea Diseases 0.000 abstract 1
- 206010012335 Dependence Diseases 0.000 abstract 1
- 208000016285 Movement disease Diseases 0.000 abstract 1
- 206010033888 Paraphilia Diseases 0.000 abstract 1
- 208000027520 Somatoform disease Diseases 0.000 abstract 1
- 206010044074 Torticollis Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 208000016620 Tourette disease Diseases 0.000 abstract 1
- 208000014679 binge eating disease Diseases 0.000 abstract 1
- 208000022266 body dysmorphic disease Diseases 0.000 abstract 1
- 208000012601 choreatic disease Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 208000018197 inherited torticollis Diseases 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 239000012453 solvate Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Reproductive Health (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0517193.9A GB0517193D0 (en) | 2005-08-22 | 2005-08-22 | Novel use |
| PCT/EP2006/008314 WO2007022980A1 (en) | 2005-08-22 | 2006-08-21 | Use of azabicyclo hexane derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE500826T1 true ATE500826T1 (de) | 2011-03-15 |
Family
ID=35098098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06777058T ATE500826T1 (de) | 2005-08-22 | 2006-08-21 | Verwendung von azabicyclohexan-derivaten |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US20090036461A1 (de) |
| EP (1) | EP1917013B1 (de) |
| JP (1) | JP5166267B2 (de) |
| KR (1) | KR101363090B1 (de) |
| CN (1) | CN101291669B (de) |
| AT (1) | ATE500826T1 (de) |
| AU (1) | AU2006284077B2 (de) |
| BR (1) | BRPI0614929A2 (de) |
| CA (1) | CA2620090A1 (de) |
| CR (1) | CR9807A (de) |
| DE (1) | DE602006020589D1 (de) |
| EA (1) | EA016084B1 (de) |
| ES (1) | ES2361933T3 (de) |
| GB (1) | GB0517193D0 (de) |
| IL (1) | IL189435A0 (de) |
| MA (1) | MA29774B1 (de) |
| MX (1) | MX2008002564A (de) |
| NO (1) | NO20081314L (de) |
| WO (1) | WO2007022980A1 (de) |
| ZA (1) | ZA200801352B (de) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1745040B9 (de) * | 2004-02-23 | 2010-06-02 | Glaxo Group Limited | Als modulatoren des dopamin-d3-rezeptors geeignete azabicyclo[3.1.0]hexanderivate |
| US20070043100A1 (en) | 2005-08-16 | 2007-02-22 | Hagen Eric J | Novel polymorphs of azabicyclohexane |
| GB0507601D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| JP5068747B2 (ja) * | 2005-06-14 | 2012-11-07 | グラクソ グループ リミテッド | ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキサン誘導体 |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| RU2008107336A (ru) | 2005-07-27 | 2009-09-10 | Дов Фармасьютикал, Инк. (Us) | Новые 1-арил-з-азабицикло{3.1.0.} гексаны: получение и применение для лечения психоневрологических расстройств |
| JP5237807B2 (ja) * | 2005-08-22 | 2013-07-17 | グラクソ グループ リミテッド | ドーパミンｄ３受容体の調節因子としてのトリアゾール誘導体 |
| GB0517191D0 (en) | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| GB0517175D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| DE602007012531D1 (de) * | 2006-04-03 | 2011-03-31 | Glaxo Group Ltd | Azabicycloä3.1.0ühexanderivate als modulatoren von dopamin-d3-rezeptoren |
| EP2007751B1 (de) * | 2006-04-03 | 2013-08-21 | Glaxo Group Limited | Azabicyclo[3.1.0]hexylderivate als modulatoren von dopamin-d3-rezeptoren |
| GB0607899D0 (en) | 2006-04-03 | 2006-05-31 | Glaxo Group Ltd | Process for preparing heterocyclic derivatives |
| US20080045725A1 (en) | 2006-04-28 | 2008-02-21 | Murry Jerry A | Process For The Synthesis of (+) And (-)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane |
| GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
| US8138377B2 (en) | 2006-11-07 | 2012-03-20 | Dov Pharmaceutical, Inc. | Arylbicyclo[3.1.0]hexylamines and methods and compositions for their preparation and use |
| WO2008153937A2 (en) * | 2007-06-06 | 2008-12-18 | Dov Pharmaceutical, Inc. | Novel 1- heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| US9133159B2 (en) | 2007-06-06 | 2015-09-15 | Neurovance, Inc. | 1-heteroaryl-3-azabicyclo[3.1.0]hexanes, methods for their preparation and their use as medicaments |
| BR112012000657A2 (pt) * | 2009-06-26 | 2016-11-16 | Panacea Biotec Ltd | novos azabicilohexanos |
| WO2012033956A1 (en) | 2010-09-08 | 2012-03-15 | Mithridion, Inc. | Cognition enhancing compounds and compositions, methods of making, and methods of treating |
| US20140206740A1 (en) | 2011-07-30 | 2014-07-24 | Neurovance, Inc. | Use Of (1R,5S)-(+)-(Napthalen-2-yl)-3-Azabicyclo[3.1.0]Hexane In The Treatment Of Conditions Affected By Monoamine Neurotransmitters |
| US9314600B2 (en) | 2012-04-15 | 2016-04-19 | Bioconnect Systems, Inc. | Delivery system for implantable flow connector |
| JP7250405B2 (ja) | 2018-01-26 | 2023-04-03 | 塩野義製薬株式会社 | ドーパミンｄ３受容体拮抗作用を有する環式化合物 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI244481B (en) * | 1998-12-23 | 2005-12-01 | Pfizer | 3-azabicyclo[3.1.0]hexane derivatives useful in therapy |
| US20020103198A1 (en) * | 2000-12-04 | 2002-08-01 | Fliri Anton F.J | Acylamino cyclopropane derivatives |
| EP1745040B9 (de) * | 2004-02-23 | 2010-06-02 | Glaxo Group Limited | Als modulatoren des dopamin-d3-rezeptors geeignete azabicyclo[3.1.0]hexanderivate |
| SE526837C2 (sv) * | 2004-02-24 | 2005-11-08 | Kongsberg Automotive Asa | Växelspakstransmission |
| WO2006058753A1 (en) * | 2004-12-02 | 2006-06-08 | Abbott Gmbh & Co. Kg | Triazole compounds suitable for treating disorders that respond to modulaiont of the dopamine d3 receptor |
| GB0507602D0 (en) * | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| GB0507601D0 (en) | 2005-04-14 | 2005-05-18 | Glaxo Group Ltd | Compounds |
| GB0507680D0 (en) * | 2005-04-15 | 2005-05-25 | Glaxo Group Ltd | Compounds |
| GB0512099D0 (en) * | 2005-06-14 | 2005-07-20 | Glaxo Group Ltd | Compounds |
| JP5068747B2 (ja) * | 2005-06-14 | 2012-11-07 | グラクソ グループ リミテッド | ドーパミンｄ３受容体のモジュレーターとしてのアザビシクロ［３．１．０］ヘキサン誘導体 |
| GB0517175D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| JP5237807B2 (ja) * | 2005-08-22 | 2013-07-17 | グラクソ グループ リミテッド | ドーパミンｄ３受容体の調節因子としてのトリアゾール誘導体 |
| GB0517191D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| GB0517187D0 (en) * | 2005-08-22 | 2005-09-28 | Glaxo Group Ltd | Compounds |
| US7727988B2 (en) * | 2006-04-03 | 2010-06-01 | Glaxo Group Limited | Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione |
| GB0616574D0 (en) * | 2006-08-21 | 2006-09-27 | Glaxo Group Ltd | Compounds |
-
2005
- 2005-08-22 GB GBGB0517193.9A patent/GB0517193D0/en not_active Ceased
-
2006
- 2006-08-21 CN CN2006800389371A patent/CN101291669B/zh not_active Expired - Fee Related
- 2006-08-21 WO PCT/EP2006/008314 patent/WO2007022980A1/en not_active Ceased
- 2006-08-21 US US12/064,119 patent/US20090036461A1/en not_active Abandoned
- 2006-08-21 EA EA200800655A patent/EA016084B1/ru not_active IP Right Cessation
- 2006-08-21 BR BRPI0614929-4A patent/BRPI0614929A2/pt not_active IP Right Cessation
- 2006-08-21 DE DE602006020589T patent/DE602006020589D1/de active Active
- 2006-08-21 CA CA002620090A patent/CA2620090A1/en not_active Abandoned
- 2006-08-21 AU AU2006284077A patent/AU2006284077B2/en not_active Ceased
- 2006-08-21 AT AT06777058T patent/ATE500826T1/de not_active IP Right Cessation
- 2006-08-21 EP EP06777058A patent/EP1917013B1/de active Active
- 2006-08-21 ES ES06777058T patent/ES2361933T3/es active Active
- 2006-08-21 JP JP2008527394A patent/JP5166267B2/ja not_active Expired - Fee Related
- 2006-08-21 MX MX2008002564A patent/MX2008002564A/es active IP Right Grant
- 2006-08-21 KR KR1020087006993A patent/KR101363090B1/ko not_active Expired - Fee Related
-
2008
- 2008-02-08 ZA ZA2008/01352A patent/ZA200801352B/en unknown
- 2008-02-11 IL IL189435A patent/IL189435A0/en unknown
- 2008-03-11 MA MA30740A patent/MA29774B1/fr unknown
- 2008-03-11 CR CR9807A patent/CR9807A/es not_active Application Discontinuation
- 2008-03-12 NO NO20081314A patent/NO20081314L/no not_active Application Discontinuation
-
2012
- 2012-03-28 US US13/432,359 patent/US20120196910A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20080040022A (ko) | 2008-05-07 |
| EP1917013B1 (de) | 2011-03-09 |
| EA200800655A1 (ru) | 2008-08-29 |
| NO20081314L (no) | 2008-03-17 |
| ES2361933T3 (es) | 2011-06-24 |
| US20090036461A1 (en) | 2009-02-05 |
| ZA200801352B (en) | 2009-01-28 |
| AU2006284077B2 (en) | 2012-05-17 |
| EA016084B1 (ru) | 2012-02-28 |
| MA29774B1 (fr) | 2008-09-01 |
| CA2620090A1 (en) | 2007-03-01 |
| US20120196910A1 (en) | 2012-08-02 |
| DE602006020589D1 (de) | 2011-04-21 |
| MX2008002564A (es) | 2008-03-18 |
| EP1917013A1 (de) | 2008-05-07 |
| GB0517193D0 (en) | 2005-09-28 |
| WO2007022980A1 (en) | 2007-03-01 |
| JP5166267B2 (ja) | 2013-03-21 |
| CR9807A (es) | 2008-07-29 |
| CN101291669B (zh) | 2012-09-26 |
| IL189435A0 (en) | 2008-08-07 |
| KR101363090B1 (ko) | 2014-02-13 |
| BRPI0614929A2 (pt) | 2011-04-19 |
| CN101291669A (zh) | 2008-10-22 |
| JP2009506989A (ja) | 2009-02-19 |
| AU2006284077A1 (en) | 2007-03-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20081314L (no) | Anvendelse av azabicykloheksanderivater | |
| EA200601552A1 (ru) | Замещенные конденсированные гетероциклические с-гликозиды | |
| EP2546246A3 (de) | Verbindungen und Verfahren zur Behandlung oder Vorbeugung von Flavivirus-Infektionen | |
| EA201000050A1 (ru) | Замещенные бициклолактамные соединения | |
| EA200300829A1 (ru) | Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6 | |
| MA29135B1 (fr) | Potentialisateurs de recepteurs du glutamate | |
| EA200870193A1 (ru) | Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение | |
| IL189694A0 (en) | Biphenyl derivatives and their use in treating hepatitis c | |
| PT1940839E (pt) | Inibidores de piridopirimidinona pi3k alfa | |
| GEAP202415883A (en) | Macrocyclic compounds as sting agonists and methods and uses thereof | |
| ATE493418T1 (de) | Dihydrofuropyrimidine als akt- proteinkinaseinhibitoren | |
| ATE532789T1 (de) | Dihydrothienopyrimidine als akt-proteinkinase- inhibitoren | |
| IL191751A0 (en) | Pyrrolo[2,3-c]pyridine derivatives | |
| DK1483251T3 (da) | C3-cyano-epothilon-derivater | |
| DE60221425D1 (de) | Substituierte tetrazyklische pyprolochinolonderivate als phosphodiesterase-inhibitoren | |
| JO2999B1 (ar) | مركب ثلاثي حلقي و استخدامه الدوائي | |
| MXPA05008960A (es) | Oxazolidinonas de indolona antibacteriales, intermedios para su preparacion y composiciones farmaceuticas que las contienen. | |
| ATE467632T1 (de) | Pyrroloä2,3-büpyridinderivate als modulatoren des h3-rezeptors | |
| MX2007007027A (es) | Derivados piperazinilpiridina como agentes anti-obesidad. | |
| MX2010001303A (es) | Compuestos terapeuticos. | |
| ATE486071T1 (de) | Azabicycloä3.1.0ühexan-derivate als modulatoren des dopamin-d3-rezeptors | |
| DE602005007765D1 (de) | Neue indol- oder benzimidazol-derivate | |
| EA200800780A1 (ru) | Производные пиримидина и их применение в качестве открывателей калиевых каналов kcnq | |
| EA200800151A1 (ru) | Производные хинолина в качестве антибактериальных агентов | |
| ATE465151T1 (de) | 4-aryloxy-chinolin-derivate als 5-ht6-modulatoren |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |